Log in with your email address username.


[Articles] BBG-001 in very preterm infants: a randomised controlled phase 3 trial

There is no evidence of benefit for this intervention in this population; this result does not support the routine use of B breve BBG-001 for prevention of necrotising enterocolitis and late-onset sepis in very preterm infants.